Spearheading the Clinical Development of CAR-T, Treg and NK-Based Therapies with Improved Efficacy, Persistence and Safety to Pioneer Curative Treatment for Chronic Autoimmune Patients. Time: 8:00 am to 5:00 pm. Prices: USD 2599.00 - USD 5097.00. Speakers: Chris Jewell, Chief Scientific Officer, Cartesian Therapeutics, Chris Rudulier, Associate Director - Autoimmunity, Intellia Therapeutics and More